Although initially attributed to the renin-angiotensin-aldosterone system (RAAS), TGF-β1, OS, and matrix metalloproteinases (MMPs), emerging evidence suggests that endothelial dysfunction-marked by reduced NO bioavailability-serves as a pivotal mechanism in this process (16–18). This evidence concerns the gene REN and endothelial dysfunction.